Medicare beneficiary panel characteristics associated with high Part D biologic disease-modifying anti-rheumatic drug prescribing for older adults among rheumatologists

Medicine ◽

10.1097/md.0000000000025644 ◽

2021 ◽

Vol 100 (16) ◽

pp. e25644

Author(s):

Jiha Lee ◽

Chiang-Hua Chang ◽

Raymond Yung ◽

Julie P.W. Bynum

Keyword(s):

Older Adults ◽

Medicare Beneficiary ◽

Drug Prescribing ◽

Part D ◽

High Part ◽

Disease Modifying ◽

Download Full-text

168 Disease-Modifying Anti-Rheumatic Drug Prescribing by Clinical Commissioning Group: A Surrogate Marker for Service Activity

Rheumatology ◽

10.1093/rheumatology/kew133.020 ◽

2016 ◽

Keyword(s):

Surrogate Marker ◽

Drug Prescribing ◽

Service Activity ◽

Group A ◽

Disease Modifying ◽

Download Full-text

Too much choice: Older adults' decision making related to Medicare part D

PsycEXTRA Dataset ◽

10.1037/e722292011-055 ◽

2007 ◽

Author(s):

Betty E. Tanius ◽

Stacey Wood ◽

Yaniv Hanoch ◽

Thomas Rice ◽

Martina Ly ◽

...

Keyword(s):

Older Adults ◽

Decision Making ◽

Medicare Part D ◽

Medicare Part ◽

Download Full-text

Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study

Rheumatology ◽

10.1093/rheumatology/keq263 ◽

2010 ◽

Vol 50 (1) ◽

pp. 40-46 ◽

Author(s):

C. K. Iannaccone ◽

Y. C. Lee ◽

J. Cui ◽

M. L. Frits ◽

R. J. Glass ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Drug Therapy ◽

Clinical Data ◽

Sequential Study ◽

Disease Modifying ◽

Download Full-text

SAT0145 Efficacy and Safety of Sirukumab in Patients with Active Rheumatoid Arthritis despite Disease-Modifying Anti-Rheumatic Drug Treatment: Results of A Randomized, Double-Blind, Placebo-Controlled Study: Table 1.

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.3741 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 717.1-717

Author(s):

T. Takeuchi ◽

C. Thorne ◽

G. Karpouzas ◽

S. Sheng ◽

W. Xu ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Drug Treatment ◽

Active Rheumatoid Arthritis ◽

Controlled Study ◽

Efficacy And Safety ◽

Treatment Results ◽

Double Blind ◽

Double Blind Placebo ◽

Disease Modifying ◽

Download Full-text

Simplifying The Medicare Plan Finder Tool Could Help Older Adults Choose Lower-Cost Part D Plans

Health Affairs ◽

10.1377/hlthaff.2018.0145 ◽

2018 ◽

Vol 37 (8) ◽

pp. 1290-1297 ◽

Author(s):

Brian E. McGarry ◽

Nicole Maestas ◽

David C. Grabowski

Keyword(s):

Older Adults ◽

Download Full-text

Micro-structural bone changes in early rheumatoid arthritis persist over 1-year despite use of disease modifying anti-rheumatic drug therapy

BMC Musculoskeletal Disorders ◽

10.1186/s12891-017-1888-3 ◽

2017 ◽

Vol 18 (1) ◽

Author(s):

Lynne M. Feehan ◽

Linda L. Li ◽

Heather A. McKay

Keyword(s):

Rheumatoid Arthritis ◽

Drug Therapy ◽

Early Rheumatoid Arthritis ◽

Bone Changes ◽

Disease Modifying ◽

Download Full-text

Epidural abscess after lumbar medial branch blocks in a patient on disease-modifying anti-rheumatic drug and corticosteroid

Regional Anesthesia and Pain Medicine ◽

10.1136/rapm-2021-102656 ◽

2021 ◽

pp. rapm-2021-102656

Author(s):

Chiemeka Onyima ◽

Moshe Chinn ◽

May Chin

Keyword(s):

Epidural Abscess ◽

Medial Branch ◽

Disease Modifying ◽

Download Full-text

REPORT FROM THE FIRST CLINICAL TRIALS ON ALZHEIMER’S DISEASE (CTAD) ASIA-CHINA 2018 : BRINGING TOGETHER GLOBAL LEADERS

Journal of Prevention of Alzheimer's Disease ◽

10.14283/jpad.2019.2 ◽

2019 ◽

pp. 1-4

Author(s):

J.K. Chhetri ◽

P. Chan ◽

B. Vellas ◽

J. Touchon ◽

S. Gauthier

Keyword(s):

Alzheimer’S Disease ◽

Older Adults ◽

Alzheimer's Disease ◽

Clinical Trials ◽

Chinese Population ◽

The West ◽

Disease Modifying Therapies ◽

Increased Risk ◽

Disease Modifying ◽

Past Experiences

Population of older adults in Asia, and particularly in China is increasing rapidly. Older population are at increased risk of Alzheimer’s disease (AD) and other dementias. Soon, the Chinese population with AD will represent almost half of the world’s AD population. There is a desperate need of disease modifying therapies to delay or slow the progression of AD, to tackle this emerging healthcare emergency. In this context, the first CTAD Asia-China conference was held in China to bring together Western and Asian leaders in AD. This meeting focused largely on how to develop successful trials in China, utilizing past experiences from the West.

Download Full-text

THU0177 TREATMENT PATTERNS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH A BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUG OR JAK INHIBITOR: A NATION-WIDE STUDY IN KOREA

10.1136/annrheumdis-2019-eular.2777 ◽

2019 ◽

Author(s):

Min Jung Kim ◽

Anna Shin ◽

Seunghwan Shin ◽

You-Jung Ha ◽

Yun Jong Lee ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Treatment Patterns ◽

Jak Inhibitor ◽

Disease Modifying ◽

Download Full-text

Broken Promises — How Medicare Part D Has Failed to Deliver Savings to Older Adults

New England Journal of Medicine ◽

10.1056/nejmp2027580 ◽

2020 ◽

Vol 383 (24) ◽

pp. 2299-2301

Author(s):

Stacie B. Dusetzina ◽

Benyam Muluneh ◽

Nancy L. Keating ◽

Haiden A. Huskamp

Keyword(s):

Older Adults ◽

Medicare Part D ◽

Medicare Part ◽

Download Full-text